{
    "Trade/Device Name(s)": [
        "AmpliVue\u00ae HSV 1+2 Assay"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K140029",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111951"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OQO"
    ],
    "Summary Letter Date": "March 26, 2014",
    "Summary Letter Received Date": "January 6, 2014",
    "Submission Date": "December 30, 2013",
    "Regulation Number(s)": [
        "21CFR866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Nucleic Acid Amplification Assay"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Herpes Simplex Virus 1 (HSV-1)",
        "Herpes Simplex Virus 2 (HSV-2)"
    ],
    "Specimen Type(s)": [
        "Cutaneous lesion",
        "Mucocutaneous lesion"
    ],
    "Specimen Container(s)": [
        "Viral transport medium (Remel M4, Remel M4RT, Remel M5, Bartels VTM, BD UVT/Copan UTM)"
    ],
    "Instrument(s)/Platform(s)": [
        "Type III BEStTM cassette"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal Helicase-Dependent Amplification (HDA)",
        "Lateral-flow colorimetric detection"
    ],
    "Methodologies": [
        "Helicase-Dependent Amplification",
        "DNA hybridization probes",
        "Lateral-flow strip assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Cassette",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for AmpliVue\u00ae HSV 1+2 Assay for qualitative detection and differentiation of HSV-1 and HSV-2 DNA in lesion specimens using HDA and lateral-flow detection.",
    "Indications for Use Summary": "In vitro diagnostic test to directly, qualitatively detect and differentiate HSV-1 and HSV-2 DNA in cutaneous or mucocutaneous lesion specimens from symptomatic patients; aids diagnosis of HSV infection.",
    "fda_folder": "Microbiology"
}